the aid library

LIST OPTIONS

Filter

5583

Guideline on management of pneumonia and diarrhoea in children up to 10 years of age

World Health Organization WHO (2024) C_WHO

Pneumonia and diarrhoea account for 23% of under-five mortality and were responsible for an estimated 1.17 million deaths in children under five globally. Furthermore, pneumonia and diarrhoea were responsible for 18% of mortality in children 5–9 years of age, resulting in an estimated 86 000 preve... more

Download (308)

View PDF (347)

Guideline for Preventive Chemotherapy for the Control of Taenia solium Taeniasis

Pan American Health Organisation PAHO (2021) C_WHO

The larval stage of the parasite Taenia solium can encyst in the central nervous system causing neurocysticercosis, which is the main cause of acquired epilepsy in the countries in which the parasite is endemic. Endemic areas are those with the presence (or likely presence) of the full life cycle of... more

Download (246)

View PDF (337)

Report on the Review of the Kenya National Guidelines for Safe Management of Health Care Waste

UNDP (2018) CC

Injection Safety and Safe Disposal of Medical Waste National Communication Strategy and Health Care Waste Management Standard Operating Procedures (SOPs). The overall objective of the consultancy was to review and align the three national technical and communication guiding documents on HCWM to th... more

Download (154)

View PDF (155)

HEARTS in the Americas. Compendium of essential clinical tools 2023

Pan American Health Organisation PAHO (2024) CC

Since 2016, the Pan American Health Organization (PAHO) has been promoting the implementation of the HEARTS Initiative in the Americas as a regional adaptation of the World Health Organization's Global HEARTS Initiative. During this time, 33 countries in the Region of the Americas have committed to ... more

External Link

The Chagas disease study landscape: A systematic review of clinical and observational antiparasitic treatment studies to assess the potential for establishing an individual participant-level data plat

Maguire, B.J.; Dahal, P.; Rashan, S. et al. PLOS Neglected Tropical Diseases (2021) CC

PLoS Negl Trop Dis 15(8): e0009697. Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses t... more

Download (335)

View PDF (446)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (136)

View PDF (162)

HEARTS en las Américas: Compendio de herramientas clínicas esenciales 2023

Pan American Health Organisation PAHO (2024) CC

Desde el 2016, la Organización Panamericana de la Salud (OPS) ha promovido la implementación de la Iniciativa HEARTS en las Américas, una adaptación regional de la estrategia Global HEARTS de la Organización Mundial de la Salud (OMS). Durante este tiempo, 33 países de la Región de las Améric... more

Download (225)

View PDF (238)

Infection prevention and control in the context of coronavirus disease (‎COVID-19)‎: a living guideline, 10 August 2023

World Health Organization WHO (2023) C_WHO

The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline... more

Download (195)

View PDF (283)

Coronavirus SARS-CoV-2/ COVID-19 Pandemic: Information and interim guidelines for pharmacists and the pharmacy workforce

International Pharmaceutical Federation (FIP) (2020) CC

The purpose of this document is to provide relevant information and guidelines on coronavirus outbreaks – and in particular the novel coronavirus SARS-CoV-2 and the diseases it produces, COVID-19 – for pharmacists and the pharmacy workforce, both in a primary care context (i.e. community phar... more

Download (225)

View PDF (255)

Upgrading Guidelines/Information of Health Facilities and Utilities Ministry of Health Republic of Zambia March

Ministry of Health, Zambia (2016) C1

The Ministry of Health together with its partners realizes that efficient and effective delivery of clinical care is highly dependent on the availability of appropriately upgraded environment, which is in well facilitated space. Such facilities and utilities should always be properly designed, bu... more

External Link

Hepatitis B (chronic): Diagnosis and management of chronic hepatitis B in children, young people and adults

Aftab Ala, Elizabeth Boxall, Steven Bradley et al. National Clinical Guideline Centre (2013)

Clinical guideline, Methods, Evidence and Recommendations In this guideline the following is covered: information needs of people with chronic hep titis B and their carers; where children, young people and adults with chronic hepatitis B a- should be assessed; assessment of liver disease, includi... more

External Link

Guía de Práctica Clínica - Problema de Salud AUGE N°18 Síndrome de la Inmunodeficiencia Adquirida VIH/SIDA

Ministerio de Salud, Gobierno de Chile (2022) C1

Pediátrico Recomendaciones GRADE accessed August 2022

External Link

Guía de Práctica Clínica Tratamiento Farmacológico de la Diabetes Mellitus tipo 2

Ministerio de Salud, Gobierno de Chile (2018) C1

2016-2017

Download (135)

View PDF (193)

Guías de Práctica Clínica: Guía de Atención Clínica Integral del pacientecon dengue

Jeadran N. Malagon; Julio C Padilla; Diana P. Rojas-Alvarez Ministerio de la Protección Social, Colombia (2011) C1

Download (140)

View PDF (144)

Guía de Práctica Clínica Epilepsia en el Adulto

Ministerio de Salud de Chile (2020) C1

Resumen Ejecutivo

Download (100)

View PDF (150)

Guía de Práctica Clínica para el Tratamiento de Depresión en Adultos

Ministerio de Salud - Peru (2018) CC

Guìa de práctica

Download (114)

View PDF (118)

Guia de Practica clinica de Cuidados de Enfermeria unidad de hospitalizacion medicina

Ministerio de Salud - Peru (2017) C1

Las guias de Practica clinicas de Cuidados de Enfermeria constituyen los Diagnòsticos de Enfermeria que son la segunda etapa del proceso de enfermeria en la que se analizan los datos recogidos del paciente mediante la valoraciòn, con la finalidad de identificar los problemas que constituyen la bas... more

Download (1028)

View PDF (1336)

Diagnosis dan Pengelolaan Lupus Eritematosus Sistemik

Indonesian Rheumatology Association (2011) C1

Diagnosis and Management of Systemic Lupus Erythematosus

External Link

From channels to commissioning - a practical guide to epilepsy: Lecture Notes

FJ Rugg-Gunn and JE Smalls Epilepsy Society (2017) CC

This is the fifteenth edition of the lecture notes. They were first published in 1987 as a summary of the material used in the biannual epilepsy teaching weekend organised under the auspices of the UK Chapter of the International League against Epilepsy. You can download 59 different chapters in 11 ... more

Download (349)

View PDF (289)

Diagnosis and management of epilepsy in adults

Healthcare Improvement Scotland Scottish Intercollegiate Guideline Network (2018) C1

SIGN 143. A national clinical guideline Published May 2015, Revised 2018